These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16955635)

  • 1. Significance of hyperhomocysteinemia.
    Herrmann W
    Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinaemia: a critical review of old and new aspects.
    Herrmann W; Herrmann M; Obeid R
    Curr Drug Metab; 2007 Jan; 8(1):17-31. PubMed ID: 17266521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
    Herrmann W; Lorenzl S; Obeid R
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia: a new risk factor for degenerative diseases.
    Herrmann W; Knapp JP
    Clin Lab; 2002; 48(9-10):471-81. PubMed ID: 12389706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperhomocysteinemia and B-vitamin deficiency. Current clinical aspects].
    Herrmann W; Herrmann M; Obeid R
    Med Monatsschr Pharm; 2006 Aug; 29(8):291-302. PubMed ID: 16927597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations.
    de Bree A; van der Put NM; Mennen LI; Verschuren WM; Blom HJ; Galan P; Bates CJ; Herrmann W; Ullrich M; Dierkes J; Westphal S; Bouter LM; Heine RJ; Stehouwer CD; Dekker JM; Nijpels GN; Araújo F; Cunha-Ribeiro LM; Refsum H; Vollset S; Nygard O; Ueland PM
    Eur J Clin Nutr; 2005 Apr; 59(4):480-8. PubMed ID: 15674310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
    Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
    Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Homocysteine and diabetic macroangiopathy].
    Araki A
    Nihon Rinsho; 2006 Nov; 64(11):2153-8. PubMed ID: 17087311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia--the biochemical link between a weak heart and brittle bones?
    Herrmann M; Taban-Shomal O; Müller S; Gunter L; Hübner U; Böhm M; Herrmann W
    Clin Lab; 2006; 52(3-4):137-47. PubMed ID: 16584060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of folate and vitamin B(12) deficiencies associated with hyperhomocysteinemia among pregnant women.
    Park H; Kim YJ; Ha EH; Kim KN; Chang N
    Am J Perinatol; 2004 Nov; 21(8):469-75. PubMed ID: 15580543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease.
    Casais P; Meschengieser SS; Gennari LC; Alberto MF; Sanchez-Luceros A; Blanco AN; Lazzari MA
    Thromb Haemost; 2006 Jul; 96(1):19-23. PubMed ID: 16807646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.